New Clinical Trial Brings Hope for the Coeliac Community
Evrima Technologies are seeking participation for an upcoming clinical trial aimed at reducing and preventing gluten reactions for coeliacs
Share this post:
Hey Gluten Free Fam,
An exciting new clinical trial for coeliac disease is underway in New Zealand. With participants required across the country, Evrima Technologies are set to carry out a new Phase 2 trial for a medicine designed to stop immune reactions for those who react to gluten.
See below for the official press release detailing more about the trial. You can find out more information via coeliacstudy.com.
PRESS RELEASE
A new coeliac disease clinical trial is underway across New Zealand offering hope for the up to 100,000 people living with coeliac disease.
Evrima Technologies is currently calling for participants for a new Phase 2 trial, evaluating an investigational medicine designed to reduce or prevent immune reactions to gluten in people with coeliac disease.
Participation is needed for the new Phase 2 trial in New Zealand
Coeliac disease is an autoimmune condition where the body’s immune system mistakenly attacks its own healthy cells in the small intestine when gluten is consumed. Even with careful dietary management and eliminating gluten, many people continue to experience persistent symptoms such as fatigue, bloating, abdominal pain and digestive issues, significantly affecting quality of life.
The new study aims to assess the efficacy of the investigational product in active coeliac patients who have persistent symptoms and/or damage despite attempting to maintain a gluten free diet. This investigational medicine is designed to stop the immune cells from reacting to gluten by blocking the specific genetic pathway that triggers the harmful immune response.
Coeliac New Zealand’s general manager, Natalie Macaulay, says “International research indicates there could be up to 100,000 people in New Zealand with coeliac disease and of those, 30,000 are likely to be children under the age of 18. However, a large proportion of those are unaware they have the condition. Living with coeliac disease can be extremely challenging and we welcome new research and studies that may offer relief to coeliacs and future generations.”
“Living with coeliac disease can feel like a full-time job. A new clinical trial is investigating a potential new treatment that could help ease the burden and contribute to research that may improve understanding of coeliac disease. Help us shape the future. If you’re 18-75 and living with coeliac disease, this study may be suitable for you. ”
The trial, sponsored by Japanese pharmaceutical company, Chugai Pharmaceuticals, is being conducted at research facilities in Auckland, Pukekohe, Hamilton, Wellington, Christchurch and Dunedin. The study is currently looking for participants who must be aged 18-75 years and have been medically diagnosed with coeliac disease with persisting symptoms.
Charlotte Bradshaw, Founder and CEO of Evrima Technologies, says clinical research contributes to development of better treatment plans.
“Clinical trials are at the heart of medical innovation. Many people don’t realise they may be eligible to take part in research that could help improve future treatment options. We want to connect patients and healthcare professionals with credible clinical trials and make participation easier to understand and access. Getting involved can have a lasting impact on future health outcomes.”
Participation in the trial runs for around 54 weeks with regular study visits and medical monitoring. Participants will be reimbursed for reasonable expenses. Further details are available at coeliacstudy.com.
About Evrima
Evrima is a clinical trial recruitment specialist with a focus on global, patient-centred solutions. It connects a diverse range of trial participants, researchers and clinicians, delivering an optimum clinical trial recruitment and management experience. Evrima is striving to make a global impact on clinical trial timelines and enable the industry to advance medical research swiftly, so that new treatments are available as quickly as possible.
Thank you for reading these stories at A Gluten Free Family. If you would like to support the show and help us continue our work to improve awareness, education and make change in the world for coeliac disease and the gluten free diet, subscribe to our Buzzsprout.
We have access to prizes, discounts, ad-free shows, bonus content coming soon and a shoutout on the podcast as well!
